General conditions for submission of abstracts

Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2023 Congress and has adequate financial resources to attend.

1. Authors are requested to register within 10 days after having received their provisional notification of acceptance.
   
   If the abstract presenter is registered with a group, please inform the Congress Secretariat at: admin@eurogin.com and indicate the person who booked the group registration;


2. Abstracts must be submitted and presented in ENGLISH;
3. Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;
4. For proffered papers (for Free Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;
5. Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;
6. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;
7. The final decision of the Scientific Committee will be announced before December 2022;
8. Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)
9. All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference).
   The main author and the presenter can be the same person. They may also be identical to or different from the submitter);
10. The main author and the presenter must be identified (by ticking the corresponding boxes);
11. For further information and assistance please contact the scientific secretariat at admin@eurogin.com

Abstract editing instructions

1. Abstracts must be submitted through the online submission system;
   
2. Maximum length (body of abstract): 2700 characters (spaces included);
   
3. The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation;
   
4. Please avoid complex mathematical formulae; the system allows to insert simple tables;
   
5. Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned;
   
6. All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract;
   
7. Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
   
8. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
   
9. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
   
10. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
    
11. Drugs must be identified by their generic names and no company names should be mentioned in the title of the abstract.
    

Abstract topics

For review purposes, abstracts are classified according to the following list.

Select only 1 topic on our submission form:

1. HPV disease and COVID-19
   
2. Viral and molecular biology
3. Epidemiology and natural history
4. Pathogenesis
5. Immunology
6. HPV prophylactic vaccines
7. HPV therapeutic vaccines
8. Immunotherapy - Immuno-oncology - New treatments
9. HPV testing
10. HPV screening
11. Screening for women difficult to reach
12. Triage of HPV positive women
13. Self-sampling
14. Genotyping
15. Molecular markers
16. Screening methods
17. Automation in cytology
18. Methylation
19. Microbiome
20. Serology
21. New technologies
22. Artificial Intelligence
23. Diagnostic procedures / management
24. Risk management
25. Colposcopy
26. Cervical neoplasia
27. Vulvar and vaginal diseases and neoplasia
28. Anal neoplasia
29. Oral HPV infection
30. HPV and oropharynx / Head and neck cancer
31. HPV and associated skin diseases
32. Genital warts
33. HPV transmission
34. Sexually transmitted diseases and HIV infection
35. Conventional therapies
36. Economics and modelling
37. Advocacy, acceptability and psychology
38. Health education
39. Low resource settings
40. Public health
41. Fertility and HPV

*Middle income countries: Albania, Algeria, Azerbaijan, Bahamas, Barbados, Belize, Bosnia-Herzegovina, Botswana, Bulgaria, Chile, Colombia, Costa Rica, Croatia, Ecuador, Egypt, Gabon, Georgia, Grenada, Iraq, Jordan, Kazakhstan, Kosovo, Malaysia, Mauritius, Mexico, Moldova, Montenegro, Morocco, Nauru, North Macedonia, Panama, Peru, Romania, Saint Lucia, Saint Vincent and the Grenadines, Serbia, Seychelles, South Africa, Suriname, Thailand, Trinidad and Tobago, Tunisia, Turkmenistan, Uruguay

**Low income countries: Afghanistan, Angola, Armenia, Bangladesh, Belize, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, Comores, Congo Brazzaville, Congo Kinshasa, Dominican Republic, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Fiji, Gambia, Ghana, Guatemala, Guinea, Guinea Bissau, Guyana, Haiti, Honduras, India, Indonesia, Ivory Coast, Jamaica, Kenya, Kiribati, Kyrgyz Republic, Laos, Lesotho, Liberia, Madagascar, Malawi, Maldives, Mali, Marshall Islands, Mauritania, Micronesia, Mongolia, Mozambique, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Philippines, Rwanda, Samoa, Sao Tome Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, Sri Lanka, Sudan, South Sudan, Suriname, Swaziland, Tajikistan, Tanzania, Timor-Leste, Togo, Tonga, Tuvalu, Uganda, Uzbekistan, Vanuatu, Vietnam, Yemen, Zambia, Zimbabwe

CONFERENCE PASS

4 days (February 8-11)

• EUROGIN sessions (except Colposcopy Course)
• Exhibition
• Program book
• Printed materials
• Congress bag
• Local Workshop